{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:42:32Z","timestamp":1790516552210,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"European Union Seventh Framework Programme (FP7\/2007-2013)","award":["281234"],"award-info":[{"award-number":["281234"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.bbadis.2013.04.008","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T19:01:28Z","timestamp":1366225288000},"page":"1801-1806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":220,"title":["NCL diseases \u2014 clinical perspectives"],"prefix":"10.1016","volume":"1832","author":[{"given":"Angela","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfried","family":"Kohlsch\u00fctter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Simonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.04.008_bb0005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbadis.2006.06.010","article-title":"The neuronal ceroid-lipofuscinoses: from past to present","volume":"1762","author":"Haltia","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0010","series-title":"Contemporary Neurology Series","first-page":"480","article-title":"The neuronal ceroid lipofuscinoses (Batten disease)","author":"Mole","year":"2011"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2119\/molmed.2010.00241","article-title":"Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease","volume":"17","author":"Lebrun","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0025","doi-asserted-by":"crossref","first-page":"E651","DOI":"10.1002\/humu.21010","article-title":"Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship","volume":"30","author":"Lebrun","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","article-title":"New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses","volume":"79","author":"Williams","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajhg.2011.04.004","article-title":"Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6","volume":"88","author":"Arsov","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0050","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1093\/hmg\/dds089","article-title":"Mutation of the Parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis","volume":"21","author":"Bras","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajhg.2011.07.003","article-title":"Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis","volume":"89","author":"Noskova","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajhg.2012.05.023","article-title":"A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin\u2013proteasome system","volume":"91","author":"Staropoli","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0065","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/hmg\/dds558","article-title":"Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis","volume":"22","author":"Smith","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0070","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/awl107","article-title":"Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis","volume":"129","author":"Siintola","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0075","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"55","article-title":"CLN1","author":"Autti","year":"2011"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00710250","article-title":"Infantile neuronal ceroid-lipofuscinosis (INCL): diagnostic criteria","volume":"16","author":"Santavuori","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0085","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"80","article-title":"CLN2","author":"Chang","year":"2011"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.10660","article-title":"Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations","volume":"112","author":"Steinfeld","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejpn.2006.04.002","article-title":"Novel CLN1 mutation in two Italian sibs with late infantile neuronal ceroid lipofuscinosis","volume":"10","author":"Bonsignore","year":"2006","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0100","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"140","article-title":"CLN5","author":"Aberg","year":"2011"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0105","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"159","article-title":"CLN6","author":"Alroy","year":"2011"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0110","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"176","article-title":"CLN7","author":"Elleder","year":"2011"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0115","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"189","article-title":"CLN8","author":"Aiello","year":"2011"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1750-3639.2000.tb00255.x","article-title":"Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis","volume":"10","author":"Herva","year":"2000","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0125","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"110","article-title":"CLN3","author":"\u00c5berg","year":"2011"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1468-1331.2007.01668.x","article-title":"Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency","volume":"14","author":"Kalviainen","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ajmg.1320310614","article-title":"Kufs disease: clinical features and forms","volume":"5","author":"Berkovic","year":"1988","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"10.1016\/j.bbadis.2013.04.008_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1212\/01.wnl.0000252825.85947.2f","article-title":"Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1","volume":"68","author":"Ramadan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.04.008_bb0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3928\/00904481-20100318-04","article-title":"Identifying and managing sources of pain and distress in children with neurological impairment","volume":"39","author":"Hauer","year":"2010","journal-title":"Pediatr. Ann."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T22:20:50Z","timestamp":1539728450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913001324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0925443913001324"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.008","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NCL diseases \u2014 clinical perspectives","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}